Comparative effectiveness of drugs used to constrict the patent ductus arteriosus: a secondary analysis of the PDA-TOLERATE trial (NCT01958320)

OBJECTIVE: To evaluate the effectiveness of drugs used to constrict patent ductus arteriosus (PDA) in newborns <28 weeks. METHODS: We performed a secondary analysis of the multi-center PDA-TOLERATE trial (NCT01958320). Infants with moderate-to-large PDAs were randomized 1:1 at 8.1±2.1 days to eit...

Popoln opis

Bibliografske podrobnosti
Autores principales: Liebowitz, Melissa, Kaempf, Joseph, Erdeve, Omer, Bulbul, Ali, Håkansson, Stellan, Lindqvist, Johanna, Farooqi, Aijaz, Katheria, Anup, Sauberan, Jason, Singh, Jaideep, Nelson, Kelly, Wickremasinghe, Andrea, Dong, Lawrence, Hassinger, Denise C., Aucott, Susan W., Hayashi, Madoka, Heuchan, Anne Marie, Carey, William A., Derrick, Matthew, Wolf, Ilene Sue, Kimball, Amy, Sankar, Meera, Leone, Tina, Perez, Jorge, Serize, Arturo, Clyman, Ronald I.
Format: Online Artículo Texto
Jezik:English
Izdano: 2019
Teme:
Article
Online dostop:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561645/
https://www.ncbi.nlm.nih.gov/pubmed/30850756
http://dx.doi.org/10.1038/s41372-019-0347-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561645/
https://www.ncbi.nlm.nih.gov/pubmed/30850756
http://dx.doi.org/10.1038/s41372-019-0347-4

Podobne knjige/članki